Smoking Cessation Drugs: World Market Prospects 2012-2022


April 16, 2012
116 Pages - SKU: VSG3919779
License type:
Countries covered: Global

Smoking Cessation Drugs: World Market Prospects 2012-2022

  enlarge


What are the commercial prospects for anti-smoking treatments? Visiongain's report shows you potential revenues and trends to 2022, discussing data, opportunities and prospects.

Our investigation gives you business research and analysis with sales forecasts. It lets you assess forecasted sales at world market, submarket, product and national level to 2022.

You find analysis of prescription (Rx) and over-the-counter (OTC) therapies for smoking. How will leading products - including Nicorette, Nicotinell and Champix/Chantix - perform from 2012? Our report gives predictions and discussions of sales potential.

Also, you see forecasting of therapeutic categories to 2022, finding potential revenues:
  • Over-the-counter (OTC) smoking cessation products
  • Prescription (Rx) drugs
  • Nicotine replacement therapy (NRT)
  • Nicotine receptor partial agonists
  • Antidepressant therapy segment.
Our study lets you assess the anti-smoking R&D pipeline too, seeing trends and opportunity. You find discussions of treatments in development:
  • Nicotine vaccines
  • Monoamine oxidase inhibitors
  • Cannabinoid receptor-1 antagonists
  • Dopamine D3 antagonists
  • Opiate antagonists
  • Other agents for smoking therapy.
What does the future hold? From 2012 to 2022, the pharmaceutical industry will improve treatments for smoking cessation, with our report predicting revenue growth. R&D is promising. New formulations and generics will be important too.

Innovations in drug delivery and rising demand in developing countries will also stimulate the industry and market. The study shows you technological and commercial possibilities.

What about leading companies? Our work discusses Pfizer, GSK, Novartis and other players. You see where companies are heading from 2012.

You can investigate the future of medicine for smoking cessation now, finding revenue potentials and other trends.

Sales forecasts, market shares, developmental trends and discussions

In visiongain's report you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses (SWOT and STEP) and discussion of R&D activities. You receive 34 tables, 29 charts and three research interviews.

Eight ways Smoking Cessation Drugs: World Market Prospects 2012-2022 helps you

In particular, our study gives you the following knowledge on the topic:
  • Find potential revenues to 2022 for the world market and submarkets
  • Discover projected revenue trends of leading products to 2022
  • See market forecasting to 2022 for the US, Japan, EU5, China and India
  • Assess leading companies, discovering activities and outlooks
  • Review R&D, seeing pipeline trends by therapeutic area
  • Investigate competition and opportunities influencing sales
  • Find out what will stimulate and restrain the industry and market
  • View opinion from our survey, seeing interviews with authorities.
There, you find quantitative and qualitative analyses with independent predictions. You receive information that only our report contains, staying informed on business intelligence.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


Additional Information


Report Excerpt

4.6.3 Indian Smoking Cessation Market Still in its Infancy

In India, there is increasing awareness of the health problems associated with tobacco use. Recently, the Indian government has ended most tobacco advertising and banned smoking in public places. NRT, bupropion and Pfizer's Chantix are marketed as smoking cessation aids in India. NRT, in the form of chewing-gum and lozenges, is available OTC from shops without a prescription.

Companies Listed

22nd Century Group
Action on Smoking on Health (ASH)
Alkermes
American Heart Association (AHA)
American Lung Association (ALA)
Aradigm
Australian Therapeutic Goods Administration
Barts and The London School of Medicine and Dentistry
Biovail
Boots
Ceejay Healthcare
Celtic Pharma
Centers for Disease Control and Prevention (CDC)
Cephalon
Chinese State Tobacco Monopoly Administration (STMA)
Cytos Biotechnology
Duke University
Embera NeuroTherapeutics
European Medicines Agency (EMA)
Evolution NHS
Evotec
Food and Drug Administration (FDA)
GlaxoSmithKline (GSK)
Health Canada
Independent Pharmaceutica AB
Japanese Ministry of Health, Labour and Welfare (MHLW)
Johnson & Johnson
Karolinska Institutet
LEO Pharma
LSU Health Sciences Center - Shreveport
Mayo Clinic
Medicines and Healthcare Products Regulatory Agency (MHRA)
Nabi Biopharmaceuticals
National Cancer Institute (NCI)
National Health Service (NHS)
National Institute for Health and Clinical Excellence (NICE)
National Institute on Drug Abuse (NIDA)
National Tobacco Corp (China)
Next Safety
Novartis
Nulife
Perrigo Company
Pfizer
Philip Morris Products S.A
Queen Mary University of London
R.J. Reynolds Tobacco Company
Roche
Rock Creek Pharmaceuticals
Ruyan
Sanofi
Selecta Biosciences
Sopharma
Star Scientific
Takeda
The Cochrane Collaboration
Tobacco Dependence Research Unit
Wolfson Institute of Preventive Medicine
World Health Organization (WHO)
Zenara

More Global Smoking Cessation reports

The 2013-2018 World Outlook for Smoking Cessation Aids by Icon Group International, Inc.
The 2013-2018 World Outlook for Smoking Cessation Aids-This econometric study covers the world outlook for smoking cessation aids across more than 200 countries. For each ...
The World Market for Over The Counter (OTC) Drugs by Kalorama Information
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription.  Many pharmaceutical companies seeking more revenue and ...
Smoking Cessation: World Markets by Kalorama Information
Smoking cessation is among the most dynamic pharmaceutical markets, and one that is expected to grow despite economic conditions. More than 5 million deaths ...
Smoking Cessation Aids by Global Industry Analysts
This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are Nicotine Gum, Nicotine Patch, Nicotine lozenges ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!